In an exclusive interaction with BW Healthcare World, Sandeep Verma, Country Head for India, Bangladesh, and Sri Lanka at Bayer Consumer Health Division, shared insights on how Bayer is uniquely positioned to address the rising interest in self-care and the company's strategic plans for the Indian market
Read MoreBased on 23 human clinical trials, the study indicates that such diets contribute to a host of metabolic disorders, including diabetes, cardiovascular diseases (CVD), polycystic ovary syndrome (PCOS), non-alcoholic fatty liver disease (NAFLD), and obesity
Read MoreWith the aim of bridging the gap between healthcare and finance, CarePay leverages advanced technology to address the challenges in the current system and provide substantial benefits to patients
Read MoreIn an exclusive conversation with BW Healthcare World, Arjun Soin, Founder of Clinikally, shared his insights on the journey, challenges, and future of Clinikally in the dermatology and hair care industry
Read MoreThe seminar featured experienced mental health professionals from Artemis hospitals and other leading organisations
Read MoreFocusing sharply on its core business resulted in a 68 per cent compound annual growth rate (CAGR), reducing adjusted negative EBITDA from Rs 162 crore to Rs 17 crore
Read MoreThe company's mission focuses on reducing avoidable blindness in India by developing affordable and portable ophthalmic screening devices
Read MoreIn an exclusive conversation with BW Healthcare World, Sajeev Nair, Founder and Chairman of Vieroots Wellness Solutions, delved into how his Bengaluru-based health-tech startup is making biohacking accessible and relevant to the daily lives of busy Indians
Read MoreTraditional, manual testing methods are prone to errors and delays. Laboratory errors occur in around 0.012-0.6 per cent of test results, affecting diagnosis and patient care significantly since 60–70 per cent of diagnosis rely on these tests
Read MoreThe healthcare IT market was worth USD 303.4 billion in 2022 and is anticipated to exhibit a 13.5 per cent CAGR from 2023–2032 owing to rising investments in healthcare infrastructure in Asian countries
Read More